Jasmine practices general corporate and securities law, focusing on emerging and high-growth companies. She represents her clients through all stages of the business life cycle in matters including venture financings, mergers and acquisitions, public company offerings and corporate governance.
Cooley advised Vivace Therapeutics, a small molecule discovery and development company developing first-in-class cancer therapies targeting the Hippo pathway, on its $35 million Series D financing.
